SCHEMBL5677983

SCHEMBL5677983

BrC1CCC(Br)C(Br)CCC1Br

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
AR P10275 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25669 1.00 ALDH1A1 (0.36) ALDH1A1MAPK1HSD17B10ARTSHR
SCHEMBL15710099 1.00
SCHEMBL1958091 1.00
SCHEMBL9718773 0.85 ALDH1A1 (0.36) ALDH1A1MAPK1HSD17B10ARTSHR
SCHEMBL2437887 0.85 ALDH1A1 (0.33) ALDH1A1MAPK1HSD17B10ARTSHR
SCHEMBL9668149 0.78
SCHEMBL6900438 0.78
SCHEMBL7052054 0.78
SCHEMBL4460953 0.78 KDM4E (0.36) ALDH1A1MAPK1HSD17B10KDM4ECYP3A4
SCHEMBL10837170 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705422-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF Morehouse School of Medicine (US) 2026-03-11 EP claimed
US-20260062597-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF MOREHOUSE SCHOOL OF MEDICINE (US) 2026-03-05 US claimed
WO-2024228731-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF MOREHOUSE SCHOOL OF MEDICINE (US) 2024-11-07 WO claimed
US-20240368444-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF MOREHOUSE SCHOOL OF MEDICINE 2024-11-07 US claimed
CN-1788044-A Stabilized flame retardant additives and their use ALBEMARLE CORP (US) 2006-06-14 CN claimed
EP-1627013-A2 STABILIZED FLAME RETARDANT ADDITIVES AND THEIR USE ALBEMARLE CORPORATION (US) 2006-02-22 EP claimed
WO-2004104098-A2 STABILIZED FLAME RETARDANT ADDITIVES AND THEIR USE ALBEMARLE CORPORATION (US) 2004-12-02 WO claimed
US-20040229982-A1 Stabilized flame retardant additives and their use GOOSSENS DANIELLE F (BE) 2004-11-18 US claimed
US-5116898-A Halogenated hydrocarbon, halogenated diphenyl ether ETHYL CORPORATION (US) 1992-05-26 US claimed
US-3975327-A Particulate, expandable self-extinguishing styrene polymers showing good processability BASF AKTIENGESELLSCHAFT (DT) 1976-08-17 US claimed
JP-1304137-A None JP disclosed
JP-2123143-A None JP disclosed
EP-4705422-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF Morehouse School of Medicine (US) 2026-03-11 EP disclosed
US-20260062597-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF MOREHOUSE SCHOOL OF MEDICINE (US) 2026-03-05 US disclosed
WO-2025075003-A1 POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SULFUR BATTERIES, POSITIVE ELECTRODE MATERIAL, POSITIVE ELECTRODE, AND LITHIUM SULFUR BATTERY 国立大学法人大阪大学 2025-04-10 WO disclosed
US-4116702-A BROMINATED CYCLOALKANE AND A DISPERSANT CIBA-GEIGY CORPORATION (US) 1978-09-26 US disclosed
US-4086191-A ORGANIC BROMINE NUCLEATING AGENT BASF AKTIENGESELLSCHAFT (DT) 1978-04-25 US disclosed
US-4029614-A Particulate expandable styrene polymers having good processability BASF AKTIENGESELLSCHAFT (DT) 1977-06-14 US disclosed
US-3975327-A Particulate, expandable self-extinguishing styrene polymers showing good processability BASF AKTIENGESELLSCHAFT (DT) 1976-08-17 US disclosed
US-3956203-A BROMINATED OLIGOMER OR POLYMER OF A 1,3-DIENE BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062597-A1 METHOD AND COMPOSITION FOR ANTI-SLIPPING, AND METHOD OF MAKING THEREOF GYS1, GYS2, CUTA ALDH1A1 4405/4885MAPK1 3996/4885HSD17B10 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.